Viewing Study NCT00038194


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2025-12-26 @ 12:07 AM
Study NCT ID: NCT00038194
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2002-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module